Trial Holdings News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13:40	Evommune Halts Atopic Dermatitis Program Following Trial Failure (Benzinga)
08.09.26	Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling (Benzinga)
08.09.26	Inhibrx Biosciences Plans Head and Neck Cancer Trial Expansion Following High Response Rates (Benzinga)
08.09.26	Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff (MarketWatch)
08.09.26	Novartis shares sink on latest trial setback (Financial Times)
04.09.26	A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths (Benzinga)
03.09.26	Aptevo Therapeutics Reports 93% Clinical Benefit Rate in Key Leukemia Trial (Benzinga)
02.09.26	Cathie Wood Sells $15.6 Million of Tempus AI Stock After Merck-Moderna Trial Win, Ark Keeps Selling AMD Shares (Benzinga)
01.09.26	Tupac Shakur murder trial: Duane 'Keffe D' Davis guilty (Deutsche Welle)
01.09.26	Tupac Shakur murder trial: Duane 'Keffe D' Davis guilty (Deutsche Welle)
28.08.26	BioNTech Stock Dips After BNT122-01 Trial Termination (Benzinga)
27.08.26	Trial date set for alleged 9/11 mastermind (Deutsche Welle)
26.08.26	Meta dodges ‘Big Tobacco’ nightmare with $18 billion settlement in child-safety lawsuit (MarketWatch)
24.08.26	Biomea Fusion Stock Surges on Phase II Diabetes Trial Enrollment Completion (Benzinga)
21.08.26	Hong Kong convicts activists in national security trial (Deutsche Welle)
21.08.26	Meta, Google And Snap Catch a Break as Teen Drops Social Media Addiction Lawsuit Ahead of Key Trial (UPDATED) (Benzinga)
21.08.26	Hong Kong convicts activists in national security trial (Deutsche Welle)
19.08.26	Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors. (MotleyFool)
19.08.26	Prediction: The Child Safety Trial Will Have Minimal Impact on Meta Platforms Stock in the Long Run. Here's Why (MotleyFool)
19.08.26	Meta Stock Climbs as Landmark Trial Threatens $1.4 Trillion Penalties (Benzinga)
19.08.26	Tempus AI Soars as Merck-Moderna Cancer Trial Validates Personalis Acquisition (Benzinga)
19.08.26	Moderna shares nearly triple on skin cancer vaccine success (Financial Times)
19.08.26	Merck and Moderna Release Landmark Personalized Cancer Therapy Trial Success, Stocks Soar (Benzinga)
19.08.26	US: Meta hooked children, prosecutors say, as trial over social media harm begins (Deutsche Welle)
19.08.26	Jim Cramer Says Meta Stock Is Being ‘Hammered’ by Landmark Trial as Ross Gerber Demands Mark Zuckerberg ‘Pay the Piper’ (Benzinga)
19.08.26	US: Meta hooked children, prosecutors say, as trial over social media harm begins (Deutsche Welle)
18.08.26	Akari Targets Mid-2027 for Human Trial of Differentiated Cancer Therapy (Benzinga)
18.08.26	Meta trial over social media harm to children begins (Deutsche Welle)
18.08.26	US states call for big changes to Instagram and Facebook as Meta child privacy trial begins (BBC)
18.08.26	Meta trial over social media harm to children begins (Deutsche Welle)
18.08.26	Tupac Shakur murder trial opens as prosecutors say 'Keffe D' ordered 1996 killing (Deutsche Welle)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	79.66	0.28 %	K V
Alcon	55.90	0.14 %	K V
Novartis	111.66	-0.13 %	K V
Kuehne+Nagel Int	210.80	-0.61 %	K V
Roche Hldg PS	347.70	-0.80 %	K V
Amrize	33.48	-3.21 %	K V
Lonza Grp	538.00	-3.24 %	K V
ABB	78.32	-3.28 %	K V
Nestle	77.73	-3.31 %	K V
CieFinRichemont	175.10	-4.66 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Trial Holdings Aktie VALOR 125610996 / ISIN JP3635490000

Nachrichten zu Trial Holdings Inc. Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten